Jommi, C. and Ravasio, R. 2019. The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA). AboutOpen. 6, 1 (Nov. 2019), 78–85. DOI:https://doi.org/10.33393/abtpn.2019.302.